Sensei Biotherapeutics, Inc. Common Stock (SNSE)

Typically moves ±6.28% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-08-06 ESTIMATED

Across 20 earnings reports since Aug 04, 2021, Sensei Biotherapeutics, Inc. Common Stock (SNSE) has a clear post-earnings pattern. It moves ±6.28% on average after reporting and finishes higher 35.0% of the time. Its largest post-earnings gain was +20.54% (Mar 28, 2025) and its largest decline was -14.93% (Nov 14, 2024). The next earnings report is predicted for 2026-08-06 (estimated).

Earnings reactions

How SNSE moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.28%

Positive %

35.0%

Negative %

65.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 15, 2026	☀ PRE	-2.92%	open_in_new
Mar 30, 2026	☀ PRE	-9.29%	open_in_new
Nov 14, 2025	☀ PRE	-5.93%	open_in_new
Aug 05, 2025	☀ PRE	+0%	open_in_new
May 06, 2025	☀ PRE	-7.46%	open_in_new
Mar 28, 2025	☀ PRE	+20.54%	open_in_new
Nov 14, 2024	☀ PRE	-14.93%	open_in_new
Aug 06, 2024	☀ PRE	+4.5%	open_in_new
May 09, 2024	☀ PRE	-13.93%	open_in_new
Feb 28, 2024	☀ PRE	+10.84%	open_in_new
Nov 07, 2023	☀ PRE	+0%	open_in_new
Aug 03, 2023	☀ PRE	-2.44%	open_in_new
May 09, 2023	☀ PRE	-5.59%	open_in_new
Mar 28, 2023	☀ PRE	+0.38%	open_in_new
Nov 08, 2022	☀ PRE	-0.7%	open_in_new
Aug 09, 2022	☀ PRE	-7.62%	open_in_new
May 10, 2022	☀ PRE	+9.12%	open_in_new
Mar 10, 2022	☀ PRE	-7.2%	open_in_new
Nov 09, 2021	☀ PRE	-1.82%	open_in_new
Aug 04, 2021	☀ PRE	-0.48%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.28%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 6 →

Funds holding

$7470041

Total value held

Buying

6 added · 0 reduced

Franklin Resources Inc

$4208109 NEW BUY

Goldman Sachs Group Inc

$1940623 NEW BUY

Bank Of America Corp /De/

$1040948 +10692.48%

Morgan Stanley

$277218 +87850.00%

Citigroup Inc

$3137 NEW BUY

SEC Filing Types

description SCHEDULE 13G

description SCHEDULE 13G/A

1 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260723	open_in_new SEC.gov
4	20260723	open_in_new SEC.gov
8-K	20260723	open_in_new SEC.gov
4	20260701	open_in_new SEC.gov
4	20260626	open_in_new SEC.gov
4	20260624	open_in_new SEC.gov
4	20260624	open_in_new SEC.gov
3	20260623	open_in_new SEC.gov
SCHEDULE 13G	20260623	open_in_new SEC.gov
SCHEDULE 13G	20260623	open_in_new SEC.gov

Frequently asked about SNSE earnings

When does Sensei Biotherapeutics, Inc. Common Stock report earnings next? expand_more

Sensei Biotherapeutics, Inc. Common Stock (SNSE)'s next earnings date is estimated for 2026-08-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does SNSE stock move after earnings? expand_more

Over 20 reports, SNSE has moved an average of ±6.28% the session after earnings, closing higher 35.0% of the time.

What was SNSE's biggest post-earnings move? expand_more

SNSE's largest post-earnings gain on record was +20.54% on Mar 28, 2025, and its largest decline was -14.93% on Nov 14, 2024.

Where can I find Sensei Biotherapeutics, Inc. Common Stock's SEC filings? expand_more

All of Sensei Biotherapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.